Skip to main content
    A

    Anixa Biosciences Inc (ANIX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.55
    -0.07 (-2.67%)

    Market Cap: $91.08M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Anixa Biosciences Inc (ANIX) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Anixa Biosciences (ANIX) to earn -$0.31 per share in the fiscal year ending Oct 31, 2027. Of 4 analysts, 4 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the quarter ending Jan 31, 2027, the EPS consensus is -$0.08.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 1.75, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.

    RatingAnalystsShare
    Strong Buy125.0%
    Buy375.0%
    Hold00.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    4

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    Fiscal year ending Oct 31, 2027
    -$0.31
    EPS consensus
    Next report
    Jan 11, 2027
    Estimated
    Fiscal year endingEPS consensusEPS rangeEPS analysts
    Oct 31, 2027-$0.31-$0.31 to -$0.311

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analysts
    Jan 31, 2027-$0.08-$0.08 to -$0.081

    Estimate Revisions

    No EPS estimate for the 2 periods below was revised in the last 30 days.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Oct 31, 202700
    Quarter ending Jan 31, 202700

    EPS Trend

    The EPS consensus for the fiscal year ending Oct 31, 2027 has held over the last 90 days.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Oct 31, 2027-$0.31-$0.31-$0.31-$0.31-$0.31N/A
    Quarter ending Jan 31, 2027-$0.08-$0.08-$0.08-$0.08-$0.08N/A

    Frequently Asked Questions About ANIX

    What is the ANIX stock forecast?

    Consensus analyst estimates put Anixa Biosciences's EPS at -$0.31 for the fiscal year ending Oct 31, 2027. The consensus rating from 4 analysts is Buy.

    How do analysts rate ANIX stock?

    Of 4 analysts covering Anixa Biosciences, 1 rates it Strong Buy, 3 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from ANIX next year?

    For the fiscal year ending Oct 31, 2027, the consensus EPS estimate is -$0.31, with estimates from -$0.31 to -$0.31 from 1 analyst.

    How many analysts cover ANIX?

    4 analysts rate Anixa Biosciences stock, and 1 analyst estimates its EPS for the fiscal year ending Oct 31, 2027.